J

JonesTrading Latest Price Targets & Analyst Ratings

Stock Analyst Price Price Target Upside
Downside
Rating Date
TLSI icon
1
TriSalus Life Sciences
TLSI
$257M
JW
Justin Walsh
$5.15 $16
211%
upside
Buy 1 year ago
GHI icon
2
Greystone Housing Impact Investors LP
GHI
$253M
JW
Jason Weaver
$10.81 $17.50
62%
upside
Buy 1 year ago
CTO
3
CTO Realty Growth
CTO
$571M
JW
Jason Weaver
$17.34 $19
10%
upside
Buy 1 year ago
NLY icon
4
Annaly Capital Management
NLY
$14B
JW
Jason Weaver
$21.80 $21
4%
downside
Buy 1 year ago
AGNC icon
5
AGNC Investment
AGNC
$10.6B
JW
Jason Weaver
$10.20 $10.25
0%
upside
Buy 1 year ago
DX
6
Dynex Capital
DX
$1.66B
JW
Jason Weaver
$12.77 $14
10%
upside
Buy 1 year ago
RZLT icon
7
Rezolute
RZLT
$642M
CN
Catherine Novack
$7.38 $10
36%
upside
Buy 1 year ago
CGEM icon
8
Cullinan Oncology
CGEM
$408M
SR
Soumit Roy
$6.91 $26
276%
upside
Buy 1 year ago
JANX icon
9
Janux Therapeutics
JANX
$1.44B
SR
Soumit Roy
$23.94 $70
192%
upside
Buy 1 year ago
REAX icon
10
Real Brokerage
REAX
$1.1B
ME
Matthew Erdner
$5.25 $4
24%
downside
Buy 1 year ago
AGNC icon
11
AGNC Investment
AGNC
$10.6B
$10.20 $10.75
5%
upside
Buy 1 year ago
CRNX icon
12
Crinetics Pharmaceuticals
CRNX
$3.23B
LK
Lina Kaminski
$34.25 $56
64%
upside
Buy 1 year ago
GHI icon
13
Greystone Housing Impact Investors LP
GHI
$253M
JS
Jason Stewart
$10.81 $20
85%
upside
Buy 1 year ago
RITM icon
14
Rithm Capital
RITM
$6.66B
ME
Matthew Erdner
$12.56 $12
4%
downside
Buy 1 year ago
FBRT
15
Franklin BSP Realty Trust
FBRT
$959M
JS
Jason Stewart
$11.66 $15
29%
upside
Buy 1 year ago
NLY icon
16
Annaly Capital Management
NLY
$14B
ME
Matthew Erdner
$21.80 $21
4%
downside
Buy 1 year ago
DX
17
Dynex Capital
DX
$1.66B
JS
Jason Stewart
$12.77 $14
10%
upside
Buy 1 year ago
CATX icon
18
Perspective Therapeutics
CATX
$263M
JW
Justin Walsh
$3.54 $14
295%
upside
Buy 1 year ago
CTO
19
CTO Realty Growth
CTO
$571M
ME
Matthew Erdner
$17.34 $21
21%
upside
Buy 1 year ago
PRME icon
20
Prime Medicine
PRME
$606M
JW
Justin Walsh
$3.40 $20
488%
upside
Buy 2 years ago
KNTK icon
21
Kinetik
KNTK
$2.62B
ES
Eduardo Seda
$42.69 $43
1%
upside
Buy 2 years ago
EYPT icon
22
EyePoint Pharmaceuticals
EYPT
$819M
SK
Sean Kim
$11.88 $26
119%
upside
Buy 2 years ago
CTO
23
CTO Realty Growth
CTO
$571M
JS
Jason Stewart
$17.34 $26
50%
upside
Buy 2 years ago
TRVI icon
24
Trevi Therapeutics
TRVI
$880M
SK
Sean Kim
$7.23 $7
3%
downside
Buy 2 years ago
NLY icon
25
Annaly Capital Management
NLY
$14B
JS
Jason Stewart
$21.80 $22.50
3%
upside
Buy 2 years ago